par Cleeland, Charles S;Body, Jean-Jacques ;Stopeck, Alison;von Moos, Roger;Fallowfield, Lesley J;Mathias, Susan D;Patrick, Donald L;Clemons, Mark J;Tonkin, Katia;Masuda, Norikazu;Lipton, Allan;De Boer, Richard;Salvagni, Stefania;Oliveira, Celia Tosello;Qian, Yi;Jiang, Qi;Dansey, Roger;Braun, Ada;Chung, Karen
Référence Cancer, 119, 4, page (832-838)
Publication Publié, 2013-02
Référence Cancer, 119, 4, page (832-838)
Publication Publié, 2013-02
Article révisé par les pairs
Résumé : | In this study, the authors evaluated the effect of denosumab versus zoledronic acid (ZA) on pain in patients with advanced breast cancer and bone metastases. |